ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 133937" data-attributes="member: 13851"><p><strong>Abstract</strong></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Purpose</span></strong> The aim of the present systematic review and meta-analysis was to summarize evidence on the effectiveness of testosterone supplementation for poor ovarian responders (POR) on IVF outcomes. The primary outcome was live birth rate (LBR); secondary outcomes were clinical pregnancy rate(CPR), miscarriage rate (MR), total and MII oocytes, and total embryos. </p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Methods</span></strong> This meta-analysis of randomized controlled trials (RCTs) evaluates the effects of testosterone administration before/ during COS compared with a control group in patients defined as POR. The primary outcome was live birth rate (LBR); secondary outcomes were clinical pregnancy rate (CPR), miscarriage rate (MR), total and MII oocytes, and total embryos. Pooled results were expressed as risk ratio (RR) or mean differences (MD) with 95% confidence interval (95% CI). Sources of heterogeneity were investigated through sensitivity and subgroup analysis. All analyses were performed by using the random effects model. </p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Results</span></strong> Women receiving testosterone showed higher LBR (RR 2.29, 95% CI 1.31–4.01, p=0.004), CPR (RR 2.32, 95% CI 1.47–3.64, p=0.0003), total oocytes (MD=1.28 [95% CI 0.83, 1.73], p<0.00001), MII oocytes (MD=0.96 [95% CI 0.28, 1.65],p=0.006),and total embryos (MD=1.17[95% CI 0.67,1.67], p<0.00001) in comparison to controls, with no difference in MR (p=ns). Sensitivity and subgroup analysis did not provide statistical changes to the pooled results. </p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Conclusions </span></strong>Testosterone therapy seems promising to improve the success at IVF in POR patients. Further RCTs with rigorous methodology and inclusion criteria are still mandatory.</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong>Conclusions</strong></p><p>Pre-treatment with testosterone seems promising to improve the success of IVF in POR patients. Specifically, available data support a positive impact of transdermal testosterone on LBR, CPR, and other COS parameters (total number of oocytes and MII oocytes retrieved, total embryos obtained). Due to the limitations of available studies, further RCTs on larger populations, with rigorous methodology and inclusion criteria, are still mandatory in order to finally confirm or not its real clinical effectiveness as well as to establish the best timing, dose, and duration of testosterone administration before IVF.</p></blockquote><p></p>
[QUOTE="madman, post: 133937, member: 13851"] [B]Abstract[/B] [B][COLOR=rgb(184, 49, 47)]Purpose[/COLOR][/B] The aim of the present systematic review and meta-analysis was to summarize evidence on the effectiveness of testosterone supplementation for poor ovarian responders (POR) on IVF outcomes. The primary outcome was live birth rate (LBR); secondary outcomes were clinical pregnancy rate(CPR), miscarriage rate (MR), total and MII oocytes, and total embryos. [B][COLOR=rgb(184, 49, 47)]Methods[/COLOR][/B] This meta-analysis of randomized controlled trials (RCTs) evaluates the effects of testosterone administration before/ during COS compared with a control group in patients defined as POR. The primary outcome was live birth rate (LBR); secondary outcomes were clinical pregnancy rate (CPR), miscarriage rate (MR), total and MII oocytes, and total embryos. Pooled results were expressed as risk ratio (RR) or mean differences (MD) with 95% confidence interval (95% CI). Sources of heterogeneity were investigated through sensitivity and subgroup analysis. All analyses were performed by using the random effects model. [B][COLOR=rgb(184, 49, 47)]Results[/COLOR][/B] Women receiving testosterone showed higher LBR (RR 2.29, 95% CI 1.31–4.01, p=0.004), CPR (RR 2.32, 95% CI 1.47–3.64, p=0.0003), total oocytes (MD=1.28 [95% CI 0.83, 1.73], p<0.00001), MII oocytes (MD=0.96 [95% CI 0.28, 1.65],p=0.006),and total embryos (MD=1.17[95% CI 0.67,1.67], p<0.00001) in comparison to controls, with no difference in MR (p=ns). Sensitivity and subgroup analysis did not provide statistical changes to the pooled results. [B][COLOR=rgb(184, 49, 47)]Conclusions [/COLOR][/B]Testosterone therapy seems promising to improve the success at IVF in POR patients. Further RCTs with rigorous methodology and inclusion criteria are still mandatory. [B]Conclusions[/B] Pre-treatment with testosterone seems promising to improve the success of IVF in POR patients. Specifically, available data support a positive impact of transdermal testosterone on LBR, CPR, and other COS parameters (total number of oocytes and MII oocytes retrieved, total embryos obtained). Due to the limitations of available studies, further RCTs on larger populations, with rigorous methodology and inclusion criteria, are still mandatory in order to finally confirm or not its real clinical effectiveness as well as to establish the best timing, dose, and duration of testosterone administration before IVF. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top